In a pandemic the pharmaceutical industry is hailed as a saviour; yet the industry is using the crisis to lock in its problematic, profit-maximising model. Pushing for public money with no-strings-attached, and stronger monopoly patent rules, the industry’s wish-list could restrict access to COVID-19 drugs and vaccines, prolonging the pandemic in the name of profit. Control over prices and access must not be left in private hands: health is a human right.
Related Articles

Austerity
DW: France hit by more strikes against pension reform
December 17, 2019
Mathew D. Rose
Austerity, EU politics, National Politics, Neo-Liberalism in the EU
0
From Eiffel Tower operators to hospital doctors, the strikes have drawn French workers from major sectors of the economy. But the French could be losing their appetite for disruption as the holidays draw near. Read […]

EU politics
Nathaniel Flakin – German Elites Are Redefining Antisemitism so They Can Be the Victims
‘Berlin’s cultural senator has announced that public funding for artists will depend on a loyalty oath for Israel. This has nothing to do with fighting antisemitism — it’s a smokescreen to cover the German establishment’s […]

Economics
Wolfgang Münchau: the end of the German era
August 28, 2023
Ben Wray
Economics, EU politics, Finance, National Politics, Neo-Liberalism in the EU
0
This interview with Freddie Sayers in ‘UnHerd’ is an interesting analysis of Germany’s political and economic decline. Read the article HERE.
Be the first to comment